Race Oncology Limited (ASX:RAC)

Race Oncology Revenue

Race Oncology had revenue of 5.25M AUD in the half year ending December 31, 2024, with 297.47% growth. This brings the company's revenue in the last twelve months to 5.25M, down -9.65% year-over-year. In the fiscal year ending June 30, 2024, Race Oncology had annual revenue of 4.00M with 27.73% growth.

• Revenue (ttm): 5.25M
• Revenue Growth: -9.65%
• P/S Ratio: 37.04
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 199.78M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.00M	869.09K	27.73%
Jun 30, 2023	3.13M	2.43M	342.83%
Jun 30, 2022	707.81K	320.42K	82.71%
Jun 30, 2021	387.39K	228.01K	143.07%
Jun 30, 2020	159.37K	-69.13K	-30.25%